Literature DB >> 19818937

Exanthem subitum-associated encephalitis: nationwide survey in Japan.

Tetsushi Yoshikawa1, Masahiro Ohashi, Fumi Miyake, Ayano Fujita, Chie Usui, Ken Sugata, Sadao Suga, Shuji Hashimoto, Yoshizo Asano.   

Abstract

We sought to clarify clinical features of exanthem subitum associated-encephalitis/encephalopathy, generally caused by primary human herpesvirus-6 infection in Japan. A two-part questionnaire was sent to hospitals between January 2003-December 2004. Of 3357 questionnaires, 2357 (70.2%) were returned, and 2293 (68.3%) were eligible for analysis. Eighty-six cases of exanthem subitum-associated encephalitis/encephalopathy were reported. Seventy-seven (89.5%) of 86 patients were diagnosed with human herpesvirus-6 infection by virologic examination. Although 41 (50.6%) of 81 patients had no sequelae, 38 (46.9%) had neurologic sequelae. Moreover, two fatal cases (2.5%) were reported. Pleocytosis was evident in only 4 (7.5%) of 53 patients, and cerebrospinal fluid protein levels were within normal range (23.4 +/- 14.6 mg/dL S.D.) in all patients. Human herpesvirus-6 DNA was detected in 21 (53.8%) of 39 patients. Abnormal computed tomography findings were a predictor of neurologic sequelae (P = 0.0097). As a consequence of this survey, we estimate that 61.9 cases of exanthem subitum-associated encephalitis occur every year. The disease prognosis was unexpectedly poor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818937     DOI: 10.1016/j.pediatrneurol.2009.05.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  16 in total

Review 1.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

2.  HHV6 meningoencephalitis sequelae in previously healthy children.

Authors:  E Bozzola; A Krzysztofiak; M Bozzola; V Calcaterra; A Quondamcarlo; L Lancella; A Villani
Journal:  Infection       Date:  2012-07-18       Impact factor: 3.553

Review 3.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

Review 4.  Clinical impact of primary infection with roseoloviruses.

Authors:  Brenda L Tesini; Leon G Epstein; Mary T Caserta
Journal:  Curr Opin Virol       Date:  2014-10-14       Impact factor: 7.090

5.  Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases.

Authors:  Soichiro Ishimaru; Yoshiki Kawamura; Hiroki Miura; Sayuri Shima; Akihiro Ueda; Hirohisa Watanabe; Tatsuro Mutoh; Tetsushi Yoshikawa
Journal:  J Neurovirol       Date:  2021-12-30       Impact factor: 2.643

Review 6.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Prevalence of HHV-6 in cerebrospinal fluid of children younger than 2 years of age with febrile convulsion.

Authors:  Setareh Mamishi; Laura Kamrani; Masoud Mohammadpour; Jila Yavarian
Journal:  Iran J Microbiol       Date:  2014-04

Review 8.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

9.  Detection of human herpesvirus 6 in cerebrospinal fluid of children with possible encephalitis.

Authors:  Jila Yavarian; Nastaran Gavvami; Setareh Mamishi
Journal:  Jundishapur J Microbiol       Date:  2013-09-01       Impact factor: 0.747

10.  Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin.

Authors:  Marco Telford; Arcadi Navarro; Gabriel Santpere
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.